Genome Sequencing Strategies for Genetics Diagnosis of Patients With Intellectual Disability

NACompletedINTERVENTIONAL
Enrollment

3,825

Participants

Timeline

Start Date

March 13, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

June 16, 2025

Conditions
Intellectual Disability
Interventions
GENETIC

Trio Whole Genome Sequencing

WGS trio analysis will be performed using the genome data of the index case in addition to the genome data of his parents. This analysis will follow a consensus protocol that contains 3 obligatory steps: first of all, de novo variants (SNV, CNV and others SV) will be examined in the whole genome data set; then, a SNV/CNV/other SV analysis will be performed under a AR or X linked Mendelian mode hypothesis in the whole genomic regions of a OMIM extended list (that contains all genes already involved in human genetic diseases). Finally, analysis will focus on inherited pathogenic variants under an AD mode hypothesis (analysis of variations already reported as pathogenic in clinVar or HGMD pro; CNV or truncating variation in OMIM genes, etc). When these 3 steps analysis is completed then variants of interest identified at each step will be recorded until examination by a specific multidisciplinary meeting.

GENETIC

Simplex Whole Genome Sequencing

This analysis will be performed using only the index case following a similar strategy than the one used for the WGS trio

GENETIC

Current French Reference strategy

Actual ANPGM recommendations defined by the following analysis: Fra-X + chromosomal microarray analysis + 44GPS

Trial Locations (14)

38700

CHU de Grenoble-Alpes, La Tronche

49000

CHU d'Angers, Angers

Unknown

CHU Bordeaux, Bordeaux

Hospices Civil de Lyon, Bron

CHU Dijon, Dijon

CHRU Lille, Lille

Assistance publique - Hôpitaux de Marseille, Marseille

CHU Montpellier, Montpellier

CHU Nantes, Nantes

Assistance publique - Hôpitaux de Paris - Groupe Hospitalier Pitié Salpétrière, Paris

Assistance publique - Hôpitaux de Paris - Hôpital Necker - Enfants malades, Paris

CHU Rennes, Rennes

CHU Rouen, Rouen

CHU Strasbourg, Strasbourg

All Listed Sponsors
collaborator

Commissariat A L'energie Atomique

OTHER_GOV

collaborator

Hospices Civils de Lyon

OTHER

collaborator

Centre Hospitalier Universitaire Dijon

OTHER

collaborator

University Hospital, Rouen

OTHER

collaborator

University Hospital, Strasbourg

OTHER

collaborator

APHP

OTHER

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT04154891 - Genome Sequencing Strategies for Genetics Diagnosis of Patients With Intellectual Disability | Biotech Hunter | Biotech Hunter